IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers

International Immunopharmacology

Volumn 7, Issue 5, 2007, Pages 578-587

  Xiong, Shi Qiu ^a   Lin, Bing Liang ^b   Gao, Xiang ^c   Tang, Hao ^c   Wu, Chang You ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cellular immunity; Chronic hepatitis B; IL 12; Memory T cells

Indexed keywords

GAMMA INTERFERON; HEPATITIS B ANTIGEN; HEPATITIS B VACCINE; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MALE; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; VIRUS CARRIER;

ADOLESCENT; ADULT; ANTIGENS, SURFACE; CARRIER STATE; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOLOGIC MEMORY; INDICATORS AND REAGENTS; INTERFERON TYPE II; INTERLEUKIN-12; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MONOCYTES;

EID: 33947397924     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.12.007     Document Type: Article

References (28)

1. Gish R.G., and Locarnini S.A. Chronic hepatitis B: current testing strategies. Clin Gastroenterol Hepatol 4 (2006) 666-676
2. Lee W. Hepatitis B virus infection. N Engl J Med 24 (1997) 1733-1745
3. Yim H.J., and Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43 (2006) S173-S181
4. Kang B.Y., Kim E., and Kim T.S. Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells. Cell Signal 17 (2005) 665-673
5. Zeuzem S., and Carreno V. Interleukin-12 in the treatment of chronic hepatitis B and C. Antiviral Res 52 (2001) 181-188
6. Eirini I.R., Deepak S., Shilpa C., Ivana M., Steven R., Richard S.T., et al. Lamivudine plus Interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology 42 (2005) 1028-1036
7. Szkaradkiewicz A., Jopek A., and Wysocki J. Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection. Antiviral Res 66 1 (2005) 23-27
8. + T cells over time. J Immunol 170 (2003) 2022-2029
9. Peter V., Tinghua C., and Geert L.R. The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure. Antiviral Res 60 (2003) 67-74
10. Chen M., Sallberg M., Hughes J., Jones J., Guidotti L.G., Chisari F.V., et al. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 79 (2005) 3016-3027
11. Sagar A.V., and Genhong C. Toll-like receptors and innate antiviral responses. Curr Opin Immunol 15 (2003) 402-407
12. Schlaak J.F., Tully G., Lohr H.F., Gerken G., and Meyer zum Buschenfelde K.H. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clin Exp Immunol 115 (1999) 508-514
13. Imanishi H., Cheng J., Ikeda N., Saito M., Ohno M., Hara N., et al. Evaluation of IL-12-induced interferon-y production in vitro by peripheral blood mononuclear cells in patients with chronic liver disease. Hepatogastroenterology 50 (2003) 1502-1505
14. Arima S., Akbar S.M., Michitaka K., Horiike N., Nuriya H., Kohara M., et al. Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 11 (2003) 169-174
15. Giuseppina P., Cosimo T., Oronzo S., and Antonaci S. Relationship between IFN-γ, IL-10, and IL-12 production in chronic hepatitis C and in vitro effects of interferon-a. J Clin Immunol 20 (2000) 169-174
16. Chu C.H.J., and Lok A.S.F. Clinical significance of hepatitis B genotype. Heptology 35 (2002) 1274-1276
17. Beckebaum S., Cicinnati V.R., Zhang X., Ferencik S., Frilling A., Grosse-Wilde H., et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 109 (2003) 487-495
18. Renate G., van D.M., Dave S., and Rekha S.B. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40 (2004) 738-746
19. Zheng J., Zhou J., Qu D., Siu K.L., Lam T.W., Lo H.Y., et al. Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection B. J Viral Hepatol 11 (2004) 217-224
20. Lohr H.F., Pincel S., Bocher W.O., Bernhard H., Herzog-Hauff S., Rose-John S., et al. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12. Clin Exp Immunol 130 (2002) 107-114
21. Javier V., Clint S., and Mathew M. The role of IL-12 in providing a third signal for clonal expansion of naïve CD8 T cells. J Immunol 169 (2002) 6842-6849
22. Vingerhoets J., Michielsen P., Vanham G., Bosmans E., Paulij W., Ramon A., et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 28 (1998) 8-16
23. Jorg F.S., Glenn T., Hanns F., Gerken G., and Meyer zum Buschenfelde K.H. The presence of high amounts of HBV-DNA in serum is associated with suppressed cositmulatory effects of interleukin 12 on HBV-induced immune response. J Hepatol 30 (1999) 353-358
24. Szkaradkiewicz A., Jopek A., and Wysocki J. Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection. Antiviral Res 66 (2005) 23-27
25. Lefrancois L., and Marzo A. The descent of memory T-cell subsets. Nat Immunol 6 (2006) 618-623
26. Julie M.C., Debra C.L., and Mathew F.M. Signal 3 determines tolerance versus full activation of naïve CD8 T cells: dissociating proliferation and development of effectors function. J Exp Med 197 (2003) 1141-1151
27. Julie M.C., Christopher M.J., and Mathew F.M. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171 (2003) 5165-5171
28. Merrier B. Therapeutic vaccination for chronic infectious diseases: lessons from HIV-1. J Clin Virol 34 (2005) S9-S12